Nina Ruth Horowitz MD
Breast, Surgical Oncology (Other than Breast)
Assistant Professor, Surgery, Yale University School of Medicine
Join to View Full Profile
46 Prince StSte 301New Haven, CT 06519
Phone+1 203-562-3577
Fax+1 203-782-6864
Dr. Horowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Surgery, 1979 - 1984
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Certifications & Licensure
CT State Medical License 1983 - 2024
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 1 citationsThe Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ Patients.Amelia A Trant, Anees Chagpar, Wei Wei, Veronique Neumeister, David Rimm
Integrative Cancer Therapies. 2022-11-29 - 4 citationsAssociation of Medicaid Expansion with Post-mastectomy Reconstruction Rates.Justin Le Blanc, Mehra Golshan, Donald Lannin, Rachel Greenup, Elizabeth R Berger
Annals of Surgical Oncology. 2022-04-01 - 1 citationsAuthor Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach
NPJ Breast Cancer. 2022-02-03
Press Mentions
Connecticut's Top Doctors 2021: Over 1,500 Physicians in 66 SpecialtiesJune 1st, 2021- Neoadjuvant Durvalumab plus Weekly Nab-Paclitaxel and Dose-Dense doxorubicin/cyclophosphamide in Triple-Negative Breast CancerFebruary 8th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
